CS
KDNY
Candriam SCA’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-826,155
| Closed | -$31.7M | – | 703 |
|
|
2023
Q2 | $31.7M | Sell |
826,155
-100,000
| -11% | -$3.84M | 0.23% | 112 |
|
|
2023
Q1 | $19.7M | Hold |
926,155
| – | – | 0.14% | 169 |
|
|
2022
Q4 | $24.3M | Buy |
926,155
+55,000
| +6% | +$1.44M | 0.16% | 148 |
|
|
2022
Q3 | $17.1M | Hold |
871,155
| – | – | 0.12% | 184 |
|
|
2022
Q2 | $15.2M | Sell |
871,155
-314,159
| -27% | -$5.49M | 0.13% | 173 |
|
|
2022
Q1 | $19.4M | Buy |
1,185,314
+80,412
| +7% | +$1.32M | 0.13% | 168 |
|
|
2021
Q4 | $18M | Buy |
1,104,902
+202,365
| +22% | +$3.3M | 0.12% | 189 |
|
|
2021
Q3 | $11.5M | Buy |
902,537
+27,413
| +3% | +$350K | 0.08% | 250 |
|
|
2021
Q2 | $12.4M | Buy |
+875,124
| New | +$12.4M | 0.08% | 259 |
|
|
2019
Q4 | – | Sell |
-239,000
| Closed | -$253K | – | 811 |
|
|
2019
Q3 | $253K | Hold |
239,000
| – | – | ﹤0.01% | 719 |
|
|
2019
Q2 | $366K | Buy |
239,000
+58,000
| +32% | +$88.8K | ﹤0.01% | 768 |
|
|
2019
Q1 | $720K | Buy |
+181,000
| New | +$720K | 0.01% | 679 |
|
|
2017
Q2 | – | Sell |
-57,500
| Closed | -$618K | – | 721 |
|
|
2017
Q1 | $618K | Sell |
57,500
-337
| -0.6% | -$3.62K | 0.01% | 628 |
|
|
2016
Q4 | $659K | Hold |
57,837
| – | – | 0.02% | 579 |
|
|
2016
Q3 | $719K | Hold |
57,837
| – | – | 0.02% | 545 |
|
|
2016
Q2 | $654K | Hold |
57,837
| – | – | 0.02% | 515 |
|
|
2016
Q1 | $737K | Sell |
57,837
-542
| -0.9% | -$6.91K | 0.02% | 483 |
|
|
2015
Q4 | $1.64M | Sell |
58,379
-273
| -0.5% | -$7.68K | 0.04% | 328 |
|
|
2015
Q3 | $1.14M | Sell |
58,652
-2,021
| -3% | -$39.1K | 0.03% | 421 |
|
|
2015
Q2 | $1.84M | Buy |
+60,673
| New | +$1.84M | 0.04% | 375 |
|